Sanofi settles FCPA case for $25 million

Sep 06, 2018
Company also revamps compliance program
French pharmaceutical company Sanofi has agreed to pay more than $25 million to resolve SEC charges that its Kazakhstan and Middle East subsidiaries made corrupt payments to win business. ‘Bribery in connection with pharmaceutical sales remains a significant

Content Preview

to continue reading

Register
  • All articles online
  • Newsletter
Free
Sign up to get stories direct to your inbox
Cs logo Cs logo
Loading